Why Dupixent Keeps Regeneron A Top Big Pharma Pick
Source: SeekingAlpha
2026-02-27 08:00:00 ET
Shares of Regeneron Pharmaceuticals ( REGN ), my favorite on the monoclonal antibodies market, have risen 11.5% since the article "Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention?" ....
Read the full article on Seeking Alpha
For further details see:
Why Dupixent Keeps Regeneron A Top Big Pharma Pick
Regeneron Pharmaceuticals Inc.
NASDAQ: REGN
REGN Trading
-1.59% G/L:
$742.885 Last:
150,713 Volume:
$754.55 Open:
REGN Latest News
March 12, 2026 04:04:00 am
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
REGN Stock Data
$80,621,924,056
100,116,656
N/A
714
N/A
Biotechnology & Life Sciences
Healthcare
US
Tarrytown
